Purchases and Sales Made in Q2 2024 in Werewolf Therapeutics, Inc. (HOWL)
This table provides information about the institutional ownership of Werewolf Therapeutics, Inc. (HOWL) during Q2 2024. The information is specifically focused on institutions that hold shares of Werewolf Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-12.6K- 54.62% |
$29.5K - $85K
|
10.5K
$11K
|
|
|
Aug 14, 2024
Q2 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-35.2K- 44.15% |
$82.3K - $237K
|
44.5K
$46.7K
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-58.1K- 81.63% |
$136K - $392K
|
13.1K
$13.7K
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-64.8K- 90.51% |
$152K - $437K
|
6.79K
$7.13K
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-89.1K- 64.52% |
$209K - $602K
|
49K
$51.5K
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-109K- 92.89% |
$254K - $734K
|
8.32K
$8.73K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-121K- 69.85% |
$282K - $815K
|
52.1K
$54.7K
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-129K- 81.82% |
$301K - $868K
|
28.6K
$30K
|
|
|
Aug 13, 2024
Q2 2024
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-287K- 17.71% |
$672K - $1.94M
|
1.33M
$1.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-338K- 59.08% |
$790K - $2.28M
|
234K
$246K
|
|
|
Aug 14, 2024
Q2 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1M- 33.33% |
$2.34M - $6.75M
|
2M
$2.1M
|
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.52M- 90.05% |
$3.56M - $10.3M
|
168K
$176K
|